Medicare selects Botox and Trulicity among 15 high-cost drugs for price negotiations under new federal authority, with lower prices expected in 2028.

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

The Trump administration released the next 15 drugs subject to Medicare price negotiation, including for the first time ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...

Drugs that treat Type 2 diabetes, HIV and arthritis are among 15 new medications chosen for a Medicare drug price negotiation ...

Starting Jan. 1, 2025, millions of Americans who get their prescription drugs through Medicare could get a major financial break when a $2,000 out-of-pocket spending cap on medications goes into ...

Caremark, Express Scripts and OptumRx — the three largest pharmacy benefit managers in the U.S. — increased the number of drugs excluded from their formularies in 2023, according to a Jan. 10 blog ...

As health care moves toward a value-based payment model, the pharmacy benefit is going in the opposite direction, one that places unit cost over clinical appropriateness. Have you ever used your drug ...

Active duty families in Tricare Prime Remote in the U.S. will have a $0 copay for covered prescriptions outside military ...

Access to medicines in Medicare is reduced as the IRA is implemented Fewer drugs are covered on Medicare Part D formularies in 2025 relative to 2024 Medicines for serious conditions with high unmet ...

With appreciation for feedback from Mark Fendrick, Director of the Value-Based Insurance Design (V-BID) Center at the University of Michigan, and Daneen Seekoni, Vice President of Policy and Advocacy ...